AutoPulse Compared With Manual Technique for OHCA Patients on Outcome and CPR Process.

NCT04663009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3250

Last updated 2020-12-14

No results posted yet for this study

Summary

The AutoPulse Resuscitation System Model 100 (ZOLL Medical Corporation, Chelmsford, MA, US) ZOLL has been used as a standard treatment for a number of subjects in this trial and granted CE marking for Europe in November of 2003. The AutoPulse device is an automated, portable, battery-powered, load-band-distributing (LDB), chest compression device, which provides chest compressions as an adjunct to performing manual cardiopulmonary resuscitation (CPR). Use of the device is intended to provide consistent chest compressions without interruption to a victim of out-of-hospital cardiac arrest (OOHCA), to reduce the impact of rescuer fatigue due to application of manual CPR, and to enable rescuers to address additional patient needs. In the present study investigators will compare electronic data generated during cardiopulmonary resuscitation stored in the different multimonitores between LDB and manual chest compressions.

Conditions

  • Cardiac Arrest
  • Out-Of-Hospital Cardiac Arrest

Interventions

DEVICE

AutoPulse

A band circumflex of the chest that provide chest cage compressions.

Sponsors & Collaborators

  • Jon Erik Steen Hansen

    collaborator UNKNOWN
  • Unai Irusta Zarandona

    collaborator UNKNOWN
  • Elisabete Aramendi

    collaborator UNKNOWN
  • Erik Alonso

    collaborator UNKNOWN
  • Simone Savastano

    collaborator UNKNOWN
  • Enrico Baldi

    collaborator UNKNOWN
  • Alessandra Palo

    collaborator UNKNOWN
  • Lars Wik

    lead OTHER

Principal Investigators

  • Lars Wik, MD, PhD · Oslo University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-03
Primary Completion
2020-12-03
Completion
2020-12-03
FDA Device
Yes

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04663009 on ClinicalTrials.gov